MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) CEO Douglas Doerfler sold 27,862 shares of the company’s stock in a transaction on Thursday, April 6th. The stock was sold at an average price of $5.03, for a total transaction of $140,145.86. Following the completion of the sale, the chief executive officer now owns 333,197 shares of the […]